HYDERABAD: Bharat Biotech, which is developing Covaxin, a candidate vaccine for Covid-19, said on Friday that it has successfully completed interim analysis of phase I and II trials and is initiating phase III trials in 26,000 participants. “After successfully completing the interim analysis of Covaxin Phase 1 and 2 clinical …
Read More »Covid-19 vaccine: Bharat Biotech will conduct phase 3 trials on 26,000 volunteers
